| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-06 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.27 | 4e-05 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.27 | 8e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-05 |